| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.6 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.6 |